Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026


VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, will announce topline data from the Phase 3 X-TOLE2 study of azetukalner, a novel, potent KV7 potassium channel opener, in patients with focal onset seizures (FOS), on Monday, March 9, 2026.



Source link

  • Related Posts

    ‘Lose $1 Million in 2 Seconds’: Market Chaos Rocks Trading Desks

    Things have calmed down some the past few days and yet, unlike the short-lived crash sparked a year ago by Trump’s tariff rollout, many in the market expect the outsized…

    Pickup truck narrowly misses kids at bus stop in Maryland

    IE 11 is not supported. For an optimal experience visit our site on another browser. Charges dropped against Georgia teens in fatal prank 00:15 House calls prison guard working night…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Arizona’s buzzer-beating epic win over Iowa State delivers Big 12 what it sorely needed: the Game of the Year

    Arizona’s buzzer-beating epic win over Iowa State delivers Big 12 what it sorely needed: the Game of the Year

    The biggest AI stories of the year (so far)

    The biggest AI stories of the year (so far)

    X-Men ’97 season 2 release date just got a hint in new comics series

    X-Men ’97 season 2 release date just got a hint in new comics series

    ‘Lose $1 Million in 2 Seconds’: Market Chaos Rocks Trading Desks

    ‘Deliberate attack’: explosion damages Jewish school in Amsterdam | Netherlands

    ‘Deliberate attack’: explosion damages Jewish school in Amsterdam | Netherlands

    Michigan synagogue clergy grappling with attack: “None of us signed up for this”

    Michigan synagogue clergy grappling with attack: “None of us signed up for this”